Artificial Intelligence in Drug Discovery
En podcast av Simon Smith
12 Avsnitt
-
Nick Lynch of the Pistoia Alliance on AI as a Strategic Focus
Publicerades: 2018-08-07 -
Lucas Siow of ProteinQure on AI for Protein-Based Drugs
Publicerades: 2018-08-07 -
Regina Barzilay, AI Small Molecule Discovery and Synthesis
Publicerades: 2018-07-30 -
Tim Guilliams and David Brown, Healx, AI for Rare Diseases
Publicerades: 2018-07-26 -
John Cassidy, CEO, Cambridge Cancer Genomics, AI in Oncology
Publicerades: 2018-07-18 -
Kristen Fortney, CEO of BioAge Labs, on AI Aging Research
Publicerades: 2018-07-10 -
Sam Cooper, CEO of Phenomic AI, on Automated HCS and More
Publicerades: 2018-06-28 -
Shai Shen-Orr, Chief Scientist, CytoReason, AI in Immunology
Publicerades: 2018-06-20 -
Leila Pirhaji, CEO of ReviveMed, on AI for Metabolomics
Publicerades: 2018-06-11 -
Mostapha Benhenda of Startcrowd on AI Drug Discovery Hype
Publicerades: 2018-05-29 -
Mauro Cozzi, Researchably, AI for Better Biomedical Search
Publicerades: 2018-05-22 -
Dekel Gelbman, CEO of FDNA, on "Next-Generation Phenotyping"
Publicerades: 2018-05-14
1 / 1
Get knowledge and inspiration to apply artificial intelligence to drug development. Discover startups applying machine learning to biomedical research. Hear how biotech and pharma companies use AI to speed discovery and cut costs. Learn from academic researchers pushing boundaries in applying computation to biology. We interview leaders transforming drug development with data and algorithms. Subscribe now and never miss an episode!
